Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | FAAH | O00519 | 8/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 5/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27721216 | 0.98 | CES2 (0.39) | CES2HCAR2ALDH1A1FAAHLMNA | |
| Trifluoroacetic Acid SCHEMBL2186699 | 0.93 | HCAR2 (0.41) | CES2HCAR2ALDH1A1FAAHLMNA | |
| SCHEMBL196154 | 0.86 | ALDH1A1 (0.54) | CES2HCAR2ALDH1A1FAAHCES1 | |
| Ammonia Solution, Strong SCHEMBL27601992 | 0.84 | ALDH1A1 (0.52) | CES2HCAR2ALDH1A1FAAHCES1 | |
| SCHEMBL2363984 | 0.84 | CES2 (0.55) | CES2HCAR2ALDH1A1FAAHCES1 | |
| SCHEMBL1589356 | 0.84 | HTT (0.35) | CES2ALDH1A1 | |
| SCHEMBL2607867 | 0.83 | HCAR2 (0.39) | CES2HCAR2ALDH1A1FAAHLMNA | |
| SCHEMBL19105203 | 0.83 | HCAR2 (0.39) | CES2HCAR2ALDH1A1FAAHLMNA | |
| SCHEMBL2691990 | 0.82 | CES2 (0.58) | CES2HCAR2FAAHCES1MEN1 | |
| SCHEMBL1123659 | 0.82 | CES2 (0.58) | CES2HCAR2FAAHCES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 772 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118117169-B | Special additive for electrolyte, electrolyte and lithium ion battery | TIANMU LAKE INSTITUTE OF ADVANCED ENERGY STORAGE TECHNOLOGIES Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20250364599-A1 | LITHIUM-ION BATTERY AND ELECTRONIC APPARATUS | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2025-11-27 | — | — | US | claimed |
| EP-4654283-A1 | LITHIUM-ION BATTERY AND ELECTRONIC APPARATUS | Ningde Amperex Technology Ltd. (CN) | 2025-11-26 | — | — | EP | claimed |
| US-20250346622-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-11-13 | — | — | US | claimed |
| US-20250273737-A1 | SECONDARY BATTERY AND ELECTRIC DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-08-28 | — | — | US | claimed |
| EP-4604199-A1 | SECONDARY BATTERY AND ELECTRIC DEVICE | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2025-08-20 | — | — | EP | claimed |
| EP-4585601-A1 | NOVEL OLIGOSACCHARIDE, PRODUCTION INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, PRODUCTION METHOD FOR NOVEL OLIGOSACCHARIDE, AND PRODUCTION METHOD FOR PRODUCTION INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE | Daiichi Sankyo Company, Limited (JP) | 2025-07-16 | — | — | EP | claimed |
| US-12334499-B2 | Electrochemical device and electronic device | DONGGUAN AMPEREX TECHNOLOGY LIMITED (CN) | 2025-06-17 | — | — | US | claimed |
| US-20250158130-A1 | ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS CONTAINING SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2025-05-15 | — | — | US | claimed |
| CN-119905667-A | Flame-retardant electrolyte for high-rate sodium metal battery, and preparation method and application thereof | 北京化工大学 | 2025-04-29 | — | — | CN | claimed |
| CN-103833726-A | Tetrahydrothiophene ionic liquid, and preparation method and application thereof | OCEANS KING LIGHTING SCIENCE | 2014-06-04 | — | — | CN | claimed |
| CN-103833677-A | Pyrrole ionic liquid, and preparation method and application thereof | OCEANS KING LIGHTING SCIENCE | 2014-06-04 | — | — | CN | claimed |
| CN-103833649-A | Pyrazine ionic liquid, and preparation method and application thereof | OCEANS KING LIGHTING SCIENCE | 2014-06-04 | — | — | CN | claimed |
| CN-103833558-A | Quaternary ammonium salt ionic liquid, and preparation method and application thereof | OCEANS KING LIGHTING SCIENCE | 2014-06-04 | — | — | CN | claimed |
| CN-102633804-A | Method for preparing 7-Azabicyclo[2.2.1]heptane | UNIV CENTRAL SOUTH | 2012-08-15 | — | — | CN | claimed |
| EP-1824827-B1 | METHOD FOR PRODUCING ONIUM SALTS COMPRISING ALKYL ANIONS OR ARYL SULFONATE ANIONS OR ALKYL ANIONS OR ARYL CARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | MERCK PATENT GMBH (DE) | 2008-09-17 | — | — | EP | claimed |
| US-7420063-B2 | Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed therein | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-09-02 | — | — | US | claimed |
| WO-2005073185-A1 | NOVEL ALKYL- AND ARYL-THIOTRIFLUOROACETATES AND PROCESS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-08-11 | — | — | WO | claimed |
| US-20050159612-A1 | Novel alkyl- and aryl-thiotrifluoroacetates and process | BRISTOL-MYERS SQUIBB COMPANY | 2005-07-21 | — | — | US | claimed |
| US-4963485-A | ANTITUMOR AGENTS | ONCOGEN | 1990-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159612-A1 | Novel alkyl- and aryl-thiotrifluoroacetates and process | TAF9, TAF1, TAF1L | CES2 848/4885HCAR2 2306/4885ALDH1A1 200/4885 |
| US-20250346622-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | FUT6, FUT5, ST3GAL3 | CES2 2027/4885HCAR2 1913/4885ALDH1A1 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.